
20.6
PPG
5.2
RPG
3.3
APG
0.9
SPG
0.3
BPG
4812.6%
FG%
3453.2%
3P%
8232.3%
FT%
| Season | Team | GP | MIN | PTS | REB | AST | STL | BLK | TO | FG% | 3P% | FT% | TS% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025–26 | ORL | 34 | 30.0 | 20.6 | 5.2 | 3.3 | 0.9 | 0.3 | 1.7 | 48.1% | 34.5% | 82.3% | 58.8% |
| 2024–25 | ORL | 60 | 33.7 | 24.1 | 5.7 | 4.7 | 1.3 | 0.3 | 2.3 | 46.3% | 29.5% | 87.1% | 55.8% |
| 2023–24 | ORL | 72 | 32.5 | 19.7 | 5.3 | 3.7 | 1.1 | 0.4 | 1.9 | 48.2% | 28.1% | 85.0% | 57.5% |
| 2022–23 | ORL | 80 | 32.6 | 18.6 | 4.1 | 3.5 | 1.0 | 0.2 | 2.1 | 48.5% | 36.1% | 84.2% | 58.9% |
| 2021–22 | ORL | 79 | 30.7 | 15.2 | 4.5 | 2.9 | 0.9 | 0.4 | 1.5 | 46.8% | 35.4% | 86.3% | 55.9% |
| Season | Team | GP | MIN | PTS | REB | AST | STL | BLK | TO | FG% | 3P% | FT% | TS% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025–26 | ORL | 4 | 30.5 | 16.8 | 5.5 | 3.5 | 2.8 | 0.3 | 1.5 | 43.9% | 33.3% | 93.3% | 52.7% |
| 2024–25 | ORL | 5 | 38.8 | 25.8 | 4.8 | 5.6 | 1.2 | 0.4 | 2.0 | 44.3% | 18.9% | 76.9% | 51.0% |
| 2023–24 | ORL | 7 | 37.3 | 18.9 | 6.9 | 4.4 | 0.7 | 1.3 | 1.3 | 40.8% | 26.5% | 88.6% | 53.9% |